Equity
€263,979 ▲ 50.9%
NOSELE has made a profit in every financial year since 2007.
NOSELE
Lifetime
19 annual accounts with figures on one time axispeak €206,285 (2025)
€206,285▲ 1.5%
peak €110,806 (2023)
€89,095▼ 2.4%
peak €263,979 (2025)
€263,979▲ 50.9%
€100,603▼ 32.4%
peak 1.3 FTE (2021)
-not published
Board1 name since 2005
1 directorGUILLEN-ANAYA Miguel-Ange
Documentsfilings and deeds
25-11-202524 days late
2025micro format
Equity from €174,884 to €263,979Debts from €148,925 to €100,603Cash from €61,173 to €26,977
Key points
from the 2025 annual accountsChecked score
91
Excellent
Financially stronger than 56% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: 0.1%▲ +0.1 percentage points vs 10-2025
12-2025: < 0.1%▼ -0.1 percentage points vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: 0.1%▲ +0.1 percentage points vs 09-2026
11-2026: 0.2%▲ +0.1 percentage points vs 10-2026highest value
Financial strengthStrong
Score breakdown
raises risk
Figures for financial year 2025 (filed on 25-11-2025)
No registered site in the KBO
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €364,582
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 61% of them on solvency, 25% on liquidity, 60% on profitability and 80% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 01-04-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 31,368 companies had the same profile as NOSELE has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of NOSELE itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,368 companies, not a prediction for NOSELE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €24,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.92 (2.29 in 2024), above the usual 1.5. Short-term debt is 22.3% and cash 7.4% of total assets. 27.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 01-04-2025 was due by 01-11-2025 and was filed on 25-11-2025, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2026
not filed
2025
24 days late
2024
19 days late
2023
29 days late
2022
30 days late
2021
30 days late
2020
51 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 31 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0876435778
Change of role: GUILLEN-ANAYA Miguel-Ange, from manager to director
Director discharge: GUILLEN-ANAYA Miguel-Ange · General meeting of 28-11-2023 · Gazette deed
Capital decrease of €64,800 to €18,600
Capital from €83,400 to €18,600, 400 shares cancelled · General meeting of 02-07-2018 · Gazette deed
Incorporation
published on 13-10-2005 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NOSELE Woluwe-Saint-Pierre | €364,582 | €206,285 | 72.4% | - |
| Alain DEFRANCE -CARDIOLOGIE Verviers | €373,951 | €200,284 | 95.3% | - |
| Eric PINCK Anesthésie Marchin | €382,588 | €213,736 | 50.1% | - |
| HASSAN MEDICAL Binche | €411,297 | €205,666 | 73.4% | - |
| Dr. Vangehuchten, O.R.L. Vilvoorde | €357,792 | €220,962 | 73.4% | - |
| CABINET MEDICAL DU DOCTEUR FINIANOS Chaudfontaine | €393,676 | €188,987 | 24.7% | - |
| Docteur Régine ALBERT Lasne | €346,888 | €229,355 | 83.6% | - |
These companies have the same main activity as NOSELE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €347,000 and €411,000, founded between 2004 and 2007.
Official details
Source: KBO- Status
- Active since 04-10-2005Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Financial year end
- 1 April
- Peppol
- Reachable since 05-01-2026
Annual accounts to 01-04-2025
- ≈ €380,000estimated
- €364,582▲ 12.6%
- Employeeson 01-04-2025
- 3=
- Filing
- Filed on 25-11-2025
Insights on NOSELE
NOSELE files the micro format. That format states no turnover. The gross margin rose from €78,798 in 2007 to €206,285 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NOSELE
- What is the company number of NOSELE?
- The company number of NOSELE is 0876.435.778. The VAT number is the same number with BE in front: BE 0876.435.778.
- Where is NOSELE based?
- The registered office is at Meeuwenlaan 5, 1150 Woluwe-Saint-Pierre.Company details
- What does NOSELE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of NOSELE?
- NOSELE is a private limited company (BV).
- When was NOSELE founded?
- NOSELE was founded on 04-10-2005.
- Is NOSELE still active?
- Yes, NOSELE is an active enterprise in the KBO register.
- How many employees does NOSELE have?
- NOSELE had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of NOSELE?
- The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €206,285 and 41 comparable companies (NACE 86220). It probably lies between €330,000 and €510,000.
- Is NOSELE profitable?
- In financial year 2025, NOSELE made a profit of €89,095.
- Where can I find the annual accounts of NOSELE?
- NOSELE filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.